Literature DB >> 16145106

Use of bacteriophage MS2 as an internal control in viral reverse transcription-PCR assays.

Jens Dreier1, Melanie Störmer, Knut Kleesiek.   

Abstract

Diagnostic systems based on reverse transcription (RT)-PCR are widely used for the detection of viral genomes in different human specimens. The application of internal controls (IC) to monitor each step of nucleic acid amplification is necessary to prevent false-negative results due to inhibition or human error. In this study, we designed various real-time RT-PCRs utilizing the coliphage MS2 replicase gene, which differ in detection format, amplicon size, and efficiency of amplification. These noncompetitive IC assays, using TaqMan, hybridization probe, or duplex scorpion probe techniques, were tested on the LightCycler and Rotorgene systems. In our approach, clinical specimens were spiked with the control virus to monitor the efficiency of extraction, reverse transcription, and amplification steps. The MS2 RT-PCR assays were applied for internal control when using a second target hepatitis C virus RNA in duplex PCR in blood donor screening. The 95% detection limit was calculated by probit analysis to 44.9 copies per PCR (range, 38.4 to 73.4). As demonstrated routinely, application of MS2 IC assays exhibits low variability and can be applied in various RT-PCR assays. MS2 phage lysates were obtained under standard laboratory conditions. The quantification of phage and template RNA was performed by plating assays to determine PFU or via real-time RT-PCR. High stability of the MS2 phage preparations stored at -20 degrees C, 4 degrees C, and room temperature was demonstrated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145106      PMCID: PMC1234060          DOI: 10.1128/JCM.43.9.4551-4557.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  A novel RT-PCR for reliable and rapid HCV RNA screening of blood donations.

Authors:  H Hennig; J Luhm; D Hartwig; H Klüter; H Kirchner
Journal:  Transfusion       Date:  2001-09       Impact factor: 3.157

Review 2.  Clinical virology in real time.

Authors:  Hubert G M Niesters
Journal:  J Clin Virol       Date:  2002-12       Impact factor: 3.168

3.  Use of internal standard RNA molecules for the RT-PCR amplification of the faeces-borne RNA viruses.

Authors:  Kisoon Kim; Jeongkoo Park; Yoonseok Chung; Doosung Cheon; Il-Beom Lee; Seokgyu Lee; Jaedeuk Yoon; Haewol Cho; Chulyong Song; Kwang-Ho Lee
Journal:  J Virol Methods       Date:  2002-07       Impact factor: 2.014

4.  Reduction of Norwalk virus, poliovirus 1, and bacteriophage MS2 by ozone disinfection of water.

Authors:  Gwy-Am Shin; Mark D Sobsey
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

5.  Determination of enteroviruses, hepatitis A virus, bacteriophages and Escherichia coli in Adriatic Sea mussels.

Authors:  L Croci; D De Medici; C Scalfaro; A Fiore; M Divizia; D Donia; A M Cosentino; P Moretti; G Costantini
Journal:  J Appl Microbiol       Date:  2000-02       Impact factor: 3.772

6.  TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.

Authors:  C Drosten; E Seifried; W K Roth
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus.

Authors:  A Cleland; P Nettleton; L Jarvis; P Simmonds
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

8.  High-throughput HBV DNA and HCV RNA detection system using a nucleic acid purification robot and real-time detection PCR: its application to analysis of posttransfusion hepatitis.

Authors:  Shigeki Mitsunaga; Kayoko Fujimura; Chieko Matsumoto; Rieko Shiozawa; Shinichi Hirakawa; Kazunori Nakajima; Kenji Tadokoro; Takeo Juji
Journal:  Transfusion       Date:  2002-01       Impact factor: 3.157

9.  Diagnosing herpesvirus infections by real-time amplification and rapid culture.

Authors:  G J J van Doornum; J Guldemeester; A D M E Osterhaus; H G M Niesters
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Rapid-cycle PCR and fluorimetry for detection of mycobacteria.

Authors:  Jacqueline Lachnik; Birgit Ackermann; Antje Bohrssen; Silvia Maass; Catharina Diephaus; Axel Puncken; Marion Stermann; Franz-Christoph Bange
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more
  69 in total

Review 1.  Validation of laboratory-developed molecular assays for infectious diseases.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Proof of concept for recombinant cellular controls in quantitative molecular pathogen detection.

Authors:  Peter Rossmanith; Patrick Mester; Karin Frühwirth; Sabine Fuchs; Martin Wagner
Journal:  Appl Environ Microbiol       Date:  2011-02-11       Impact factor: 4.792

3.  Quantitative PCR for determining the infectivity of bacteriophage MS2 upon inactivation by heat, UV-B radiation, and singlet oxygen: advantages and limitations of an enzymatic treatment to reduce false-positive results.

Authors:  Brian M Pecson; Luisa Valério Martin; Tamar Kohn
Journal:  Appl Environ Microbiol       Date:  2009-07-10       Impact factor: 4.792

4.  Enhanced reverse transcription-PCR assay for detection of norovirus genogroup I.

Authors:  Jens Dreier; Melanie Störmer; Dietrich Mäde; Sabine Burkhardt; Knut Kleesiek
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 5.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

6.  Adsorption of Rotavirus, MS2 Bacteriophage and Surface-Modified Silica Nanoparticles to Hydrophobic Matter.

Authors:  Kata Farkas; Arvind Varsani; Liping Pang
Journal:  Food Environ Virol       Date:  2014-10-24       Impact factor: 2.778

7.  Comprehensive Molecular Approach for Characterization of Hepatitis E Virus Genotype 3 Variants.

Authors:  Bo Wang; Dominik Harms; C Patrick Papp; Sandra Niendorf; Sonja Jacobsen; Marc Lütgehetmann; Sven Pischke; Heiner Wedermeyer; Jörg Hofmann; C-Thomas Bock
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

8.  Evaluation of novel broad-range real-time PCR assay for rapid detection of human pathogenic fungi in various clinical specimens.

Authors:  Tanja Vollmer; Melanie Störmer; Knut Kleesiek; Jens Dreier
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

9.  Effects of technological processes on the tenacity and inactivation of norovirus genogroup II in experimentally contaminated foods.

Authors:  Sascha Mormann; Mareike Dabisch; Barbara Becker
Journal:  Appl Environ Microbiol       Date:  2009-11-20       Impact factor: 4.792

10.  Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.

Authors:  Ronan J Murray; James O Robinson; Jodi N White; Frank Hughes; Geoffrey W Coombs; Julie C Pearson; Hui-Leen Tan; Glenys Chidlow; Simon Williams; Keryn J Christiansen; David W Smith
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.